Skip to main content
. 2013 May 22;8(5):e64964. doi: 10.1371/journal.pone.0064964

Figure 2. Vitamin D concentrations in 200 patients with AKI stratified by RIFLE stages.

Figure 2

(a) 25-hydroxyvitamin D: ANOVA, p = 0.083. (b) 1,25-dihydroxyvitamin D: ANOVA, p = 0.042. *p≤0.05, patients in Risk stage compared with patients in Failure stage. AKI, acute kidney injury; RIFLE, Risk, Injury, Failure, Loss, and End-stage kidney disease; ANOVA, analysis of variance.